250 related articles for article (PubMed ID: 37450118)
1. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer.
Chen H; Xu C; Fang Z; Mao S
Methods Mol Biol; 2023; 2695():165-179. PubMed ID: 37450118
[TBL] [Abstract][Full Text] [Related]
2. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
Lin SY; Linehan JA; Wilson TG; Hoon DSB
Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
[TBL] [Abstract][Full Text] [Related]
3. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
Piao XM; Cha EJ; Yun SJ; Kim WJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779
[TBL] [Abstract][Full Text] [Related]
4. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
5.
Pilala KM; Kotronopoulos G; Levis P; Giagkos GC; Stravodimos K; Vassilacopoulou D; Scorilas A; Avgeris M
JCO Precis Oncol; 2024 Apr; 8():e2300414. PubMed ID: 38579191
[TBL] [Abstract][Full Text] [Related]
6. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y
Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy in Coronary Heart Disease.
Zhu W; Li X
Methods Mol Biol; 2023; 2695():279-293. PubMed ID: 37450126
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.
Lodewijk I; Dueñas M; Rubio C; Munera-Maravilla E; Segovia C; Bernardini A; Teijeira A; Paramio JM; Suárez-Cabrera C
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149597
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
[TBL] [Abstract][Full Text] [Related]
10. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.
Stasik S; Salomo K; Heberling U; Froehner M; Sommer U; Baretton GB; Ehninger G; Wirth MP; Thiede C; Fuessel S
Clin Biochem; 2019 Feb; 64():60-63. PubMed ID: 30528938
[TBL] [Abstract][Full Text] [Related]
12. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
Kong W; Chen T; Li Y
Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer and liquid biopsies: Clinical applications and challenges.
Urabe F; Sumiyoshi T; Tashiro K; Goto T; Kimura T; Kobayashi T
Int J Urol; 2024 Jun; 31(6):617-626. PubMed ID: 38551314
[TBL] [Abstract][Full Text] [Related]
16. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy with cell free DNA: new horizons for prostate cancer.
Ponti G; Maccaferri M; Percesepe A; Tomasi A; Ozben T
Crit Rev Clin Lab Sci; 2021 Jan; 58(1):60-76. PubMed ID: 32805148
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsy in Bladder Cancer.
Cui Y; Cao M
Methods Mol Biol; 2023; 2695():111-120. PubMed ID: 37450114
[TBL] [Abstract][Full Text] [Related]
19. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.
de Nóbrega M; Dos Reis MB; Pereira ÉR; de Souza MF; de Syllos Cólus IM
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2893-2910. PubMed ID: 35922694
[TBL] [Abstract][Full Text] [Related]
20. Liquid Biopsy for Prostate and Bladder Cancer: Progress and Pitfalls.
Groen L; Schalken J
Eur Urol Focus; 2022 Jul; 8(4):904-906. PubMed ID: 36123280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
